Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
PHASE1CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
Not specified
Conditions
Cognitive DisordersHIV Infections
Interventions
DRUG
OPC 14117
Trial Locations (3)
10032
Columbia Univ, New York
14642
Univ of Rochester Med Ctr, Rochester
212876965
Johns Hopkins Hosp, Baltimore
All Listed Sponsors
lead
University of Rochester
OTHER
NCT00002148 - Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia | Biotech Hunter | Biotech Hunter